Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06941311 · ClinicalTrials.gov registry record · NA

Integrating the Youth Nominated Support Team (YST) With CBT for Black Youth With Acute Suicide Risk

A NA study of Suicide Prevention, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
36
Enrollment target
2
Study locations

NCT06941311: Recruiting NA study of Suicide Prevention, sponsored by University of Michigan.

NCT06941311 is a NA study of Suicide Prevention that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 36 participants, below the 951-participant average among 21 other Suicide Prevention trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06941311, a NA study of Suicide Prevention, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
36 participants
Enrollment target
2
Study locations

Study Summary

The investigators are modifying and testing the preliminary effectiveness and implementation of the combination of two psychosocial interventions, Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) and the computer-assisted version of the Youth-Nominated Support Team (eYST). This registration will be for Aim 2 and a pilot randomized clinical trial for Aim 3 will be registered separately. In this phase of the study, CBT-SP+eYST will be tested in an initial open trial (number of youth=6) to examine its feasibility and acceptability. Investigators will recruit Black adolescents that come to an urban emergency department (ED) for suicidal thoughts and/or behaviors to receive the intervention in an outpatient community mental health agency. The study focuses on the acute phase of CBT-SP, which is 12 sessions. Participants will nominate up to 4 caring adults in the participants lives to serve as support persons. These support persons will attend an education/orientation session to learn more about their role and how to support the youth. Youth will be assessed at baseline, 6 weeks, and 14 weeks. Parents will be assessed at baseline and 14 weeks. Support persons will be assessed at baseline and 14 weeks. Fidelity assessments will be completed by clinicians after each CBT-SP session, after the YST psycho-ed session, and weekly to document contact with the support team.

Primary Outcome

The intervention will be considered acceptable if at least 50% of eligible youth choose to enroll in the study.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP)
  • BEHAVIORAL Youth-Nominated Support Team

Study Locations (2)

Michigan

  • Children's Hospital of Michigan (CHM) Emergency Department - Detroit
  • MiSide - Detroit

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2025-05-08
Est. Completion 2026-05
Phase NA
University of Michigan

1,327 total trials

What NCT06941311 shows while recruiting

NCT06941311 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 951-participant average among 21 other Suicide Prevention trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Suicide Prevention appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) is the first listed.

NCT06941311 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06941311 about?

NCT06941311 is a clinical study titled "Integrating the Youth Nominated Support Team (YST) With CBT for Black Youth With Acute Suicide Risk". The investigators are modifying and testing the preliminary effectiveness and implementation of the combination of two psychosocial interventions, Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) and the computer-assisted version of the Youth-Nominated Support Team (eYST). This registrat...

What is the current status of trial NCT06941311?

This trial is currently recruiting. It is a NA study. The enrollment target is 36 participants. The study started on 2025-05-08. Estimated completion is 2026-05.

What conditions does trial NCT06941311 study?

This clinical trial studies the following conditions: Suicide Prevention.

What interventions are being tested in trial NCT06941311?

The interventions under investigation include: Cognitive Behavioral Therapy for Suicide Prevention (CBT-SP) (BEHAVIORAL), Youth-Nominated Support Team (BEHAVIORAL).

Who is sponsoring clinical trial NCT06941311?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06941311 being conducted?

This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06941311's enrollment target sits among peer trials

36 19th of 21 higher than 2 of 21 other Suicide Prevention trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00929006 · 36 participants · Early Phase 1

    Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism

  • NCT01891318 · 36 participants · Phase 1

    Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

  • NCT02291848 · 36 participants · Phase 1

    Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma

  • NCT02366819 · 36 participants · Phase 4

    Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06941311, the US trial registry maintained by the National Library of Medicine. NCT06941311 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.